Literature DB >> 24364785

An official American thoracic society workshop report: comparative pathobiology of fibrosing lung disorders in humans and domestic animals.

Jesse Roman, Kevin K Brown, Amy Olson, Brendan M Corcoran, Kurt J Williams.   

Abstract

BACKGROUND: The clinical outcome of idiopathic pulmonary fibrosis (IPF) is poor, with a 50% survival rate at 3 years. Furthermore, current treatments provide little amelioration of symptoms. Despite significant advances in understanding the clinical features and pathobiology of IPF, further advances have been hampered by a lack of suitable animal models of the disease. Interestingly, spontaneously occurring disorders with a similarity to IPF have been recognized in the dog, cat, horse, and donkey. These disorders share clinical and pathologic features with human IPF and are emerging diseases of veterinary importance.
PURPOSE: To improve awareness about these disorders in domestic animals and stimulate interactions between disciplines, and to facilitate the elucidation of mechanisms of fibrosing lung disorders using a comparative natural-occurrence disease model approach.
METHODS: A 1-day meeting joined physicians, veterinarians, pathologists, researchers, and advocacy experts to discuss information available in this area. A review of the literature was conducted, and an executive committee discussed the findings and prepared a summary statement during subsequent meetings.
RESULTS: Clinical, diagnostic, and treatment opportunities were identified, and common areas of interest where collaborative efforts could accelerate discovery regarding etiological factors, methods for early detection, determinants of disease progression, and novel therapies were defined.
CONCLUSIONS: Comparing fibrosing lung disorders in humans and domestic animals will allow for a better understanding of the similarities and differences among species and may offer novel insights into the underlying mechanisms of spontaneously occurring fibrotic lung diseases.

Entities:  

Mesh:

Year:  2013        PMID: 24364785     DOI: 10.1513/AnnalsATS.201309-321ST

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  4 in total

Review 1.  Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.

Authors:  Marek Barczyk; Matthias Schmidt; Sabrina Mattoli
Journal:  Stem Cell Rev Rep       Date:  2015-08       Impact factor: 5.739

Review 2.  Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis.

Authors:  Jun Tashiro; Gustavo A Rubio; Andrew H Limper; Kurt Williams; Sharon J Elliot; Ioanna Ninou; Vassilis Aidinis; Argyrios Tzouvelekis; Marilyn K Glassberg
Journal:  Front Med (Lausanne)       Date:  2017-07-28

3.  Increased hemoglobin-oxygen affinity ameliorates bleomycin-induced hypoxemia and pulmonary fibrosis.

Authors:  Xin Geng; Kobina Dufu; Athiwat Hutchaleelaha; Qing Xu; Zhe Li; Chien-Ming Li; Mira P Patel; Nicholas Vlahakis; Josh Lehrer-Graiwer; Donna Oksenberg
Journal:  Physiol Rep       Date:  2016-09

4.  An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research.

Authors:  Eric S White; Zea Borok; Kevin K Brown; Oliver Eickelberg; Andreas Guenther; R Gisli Jenkins; Martin Kolb; Fernando J Martinez; Jesse Roman; Patricia Sime
Journal:  Am J Respir Crit Care Med       Date:  2016-04-01       Impact factor: 21.405

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.